Repligen (RGEN) came out with quarterly earnings of $0.33 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.53 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this drug developer would post earnings of $0.29 per share when it actually produced earnings of $0.28, delivering a surprise of -3.45%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.Repligen, which belongs to the ...